We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 61.25 | 63.00 | 0.00 | 08:00:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2021 14:13 | The NAV is c.180p Previous Management believed PDSB had potential to become a $2-4bn Company and Glycotest a £400m Company I think Glyco is most interesting as we own c.50% 50% of £400m is £200m or 20x current NSCI price if it does come off | the stigologist | |
22/3/2021 11:34 | Ta thanks both | samsung2020 | |
22/3/2021 11:17 | NSCI chat from 44 mins on link below | blakieboy7 | |
22/3/2021 11:16 | https://www.share-ta | albert arthur | |
22/3/2021 10:58 | Suprised to see this increase today, any views on why | samsung2020 | |
22/3/2021 10:03 | Tip on VOX | drradcliffe | |
22/3/2021 10:02 | Interesting move today. Busy elsewhere this morning so leak or tip? (they did promise a TU!) | loafofbread | |
21/3/2021 20:07 | I'm disgusted!! Joking :) | blakieboy7 | |
21/3/2021 19:09 | Sorry discussed lol | bmwman3 | |
21/3/2021 19:06 | Syme, futura, rambler, nsci and Orr plus others all disgust by three good pundits, excellent listening....https:/ | bmwman3 | |
17/3/2021 23:35 | Thoughts on £1 by June? | professor_az | |
17/3/2021 19:47 | This is very under the radar. Undervalued. I'm buying more. This will blossom very soon. | albert arthur | |
17/3/2021 19:21 | PDSB strong some very interesting slides being presented at Investor Conferences especially re expediting pipeline into commercial sales | the stigologist | |
12/3/2021 22:12 | It would appear those shorting PDSB are in trouble. Despite their best efforts PDSB closed at $5.65 up 38 cents (+7.21%). Monday may see a desperate effort to close remaining shorts and if so a sharp upward movement. | nextlink | |
12/3/2021 20:09 | PDSB $Billion potential sounds good. | loafofbread | |
12/3/2021 19:08 | Also, 7th ranked share on the entire LSE inclusive of AIM for lowest amount of shares in issue. And right near the top for tradable shares. | albert arthur | |
12/3/2021 19:04 | Outperform $5.27https://twitter | albert arthur | |
12/3/2021 15:53 | Why it fallen again | professor_az | |
12/3/2021 12:58 | This is looking cheap today. | albert arthur | |
11/3/2021 18:53 | The volume on PDSB today is extraordinary. The volume was much lower last time it peaked. That is a good sign. | 1airbag | |
11/3/2021 18:51 | The company are happy to confirm that assets under the Netscientific Plc umbrella are worth in excess of £20M, against todays MCap of £8M. (PDSB @ $5.50) The company are fully aware of the disconnect between the share price and NAV. Walbrook PR have been appointed to raise the investor profile of the company with an aim of reducing this inconsistency. A year end trading update is expected. The company is happy to engage with private shareholders. (My last company comms. Thought I would repost from a few weeks ago) | loafofbread | |
11/3/2021 18:42 | Definitely blue Friday tomorrow!! | blakieboy7 | |
11/3/2021 18:30 | PDSB is a train challenging year high now | the stigologist | |
11/3/2021 17:33 | Just got home and flicked screen on, so nice to see this go up. I added to my position only 2 days ago....! GLA | 1airbag | |
11/3/2021 17:28 | Decent start to a potentially longer term move higher PDSB has clinical trial results due in Q2 on its Cancer trials which are much more important but its great they have two major strings to their bow | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions